文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤放疗物理与技术

局部晚期宫颈癌调强放疗后骨盆功能不全骨折的危险因素

Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-03-15

该研究分析2008-2014年101例局部晚期宫颈癌根治性放化疗患者,中位随访25个月,20%发生骨盆功能不全骨折(PIF),其中77%位于骶骨,半数无症状。年龄>50岁是显著危险因素,PIF发生率在≤50岁和>50岁患者中分别为4%和37%;在>50岁患者中骶骨D50%是显著危险因素,将骶骨D50%从40 GyEQD2降至35 GyEQD2可使PIF风险从45%降至22%。

要点

  • 局部晚期宫颈癌放化疗后PIF发生率20%,多位于骶骨且半数无症状。
  • 年龄>50岁患者PIF发生率37%,显著高于≤50岁患者的4%。
  • >50岁患者中骶骨D50%与PIF相关,降低骶骨D50%可减少PIF风险。

核心结论

  • PIF在局部晚期宫颈癌治疗后常见,主要见于年龄>50岁患者。
  • PIF与淋巴结 boost 无关,而与 elective 盆腔靶区照射的剂量和体积相关。
  • 将 elective 处方剂量从50 Gy降至45 Gy可能显著降低PIF风险。

研究设计与样本

  • 回顾性分析2008-2014年101例接受根治性放化疗的局部晚期宫颈癌患者。
  • 患者接受每周顺铂化疗和体外放疗:淋巴结阴性患者45 Gy/25次,淋巴结阳性患者50 Gy/25次并同步整合boost 60 Gy/30次。
  • 所有患者接受脉冲剂量率磁共振引导自适应近距离放疗。

主要发现

  • 中位随访25个月,中位年龄50岁。
  • 20例(20%)诊断PIF,中位2处(范围1-3处),半数无症状。
  • 77%的骨折位于骶骨。
  • 年龄是显著危险因素(P<.001),≤50岁和>50岁患者PIF发生率分别为4%和37%。
  • 在>50岁患者中,骶骨D50%是显著危险因素(P=.04),骶骨V55Gy和盆腔骨V55Gy无统计学意义(P=.33和P=.18)。

关键数值与推荐

  • PIF定义为骨盆骨内骨折线伴或不伴硬化改变。
  • 计算骶骨以及髂骨和耻骨联合的D50%和V55Gy。
  • 在>50岁患者中,骶骨D50%从40 GyEQD2降至35 GyEQD2可使PIF风险从45%降至22%。

临床怎么用

  • 对于年龄>50岁的局部晚期宫颈癌患者,应关注骶骨D50%以降低PIF风险。
  • 考虑将 elective 盆腔放疗剂量从50 Gy降至45 Gy可能减少PIF发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the incidence of and risk factors for pelvic insufficiency fracture (PIF) after definitive chemoradiation therapy for locally advanced cervical cancer (LACC). METHODS AND MATERIALS: We analyzed 101 patients with LACC treated from 2008-2014. Patients received weekly cisplatin and underwent external beam radiation therapy with 45 Gy in 25 fractions (node-negative patients) or 50 Gy in 25 fractions with a simultaneous integrated boost of 60 Gy in 30 fractions (node-positive patients). Pulsed dose rate magnetic resonance imaging guided adaptive brachytherapy was given in addition. Follow-up magnetic resonance imaging was performed routinely at 3 and 12 months after the end of treatment or based on clinical indication. PIF was defined as a fracture line with or without sclerotic changes in the pelvic bones. D50% and V55Gy were calculated for the os sacrum and jointly for the os ileum and pubis. Patient- and treatment-related factors including dose were analyzed for correlation with PIF. RESULTS: The median follow-up period was 25 months. The median age was 50 years. In 20 patients (20%), a median of 2 PIFs (range, 1-3 PIFs) were diagnosed; half were asymptomatic. The majority of the fractures were located in the sacrum (77%). Age was a significant risk factor (P<.001), and the incidence of PIF was 4% and 37% in patients aged ≤50 years and patients aged >50 years, respectively. Sacrum D50% was a significant risk factor in patients aged >50 years (P=.04), whereas V55Gy of the sacrum and V55Gy of the pelvic bones were insignificant (P=.33 and P=.18, respectively). A dose-effect curve for sacrum D50% in patients aged >50 years showed that reduction of sacrum D50% from 40 GyEQD2 to 35 GyEQD2 reduces PIF risk from 45% to 22%. CONCLUSIONS: PIF is common after treatment of LACC and is mainly seen in patients aged >50 years. Our data indicate that PIFs are not related to lymph node boosts but rather to dose and volume associated with irradiation of the elective pelvic target. Reducing the prescribed elective dose from 50 to 45 Gy may reduce the risk of PIF considerably.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ramlov A, Pedersen EM, Røhl L, et al. Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28332986. doi:10.1016/j.ijrobp.2017.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。